11 /100
LOW RISK
Score updated May 29, 2026

HOWL — Werewolf Therapeutics, Inc. Dilution Risk Tracker

Track HOWL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HOWL — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.75 below $1 exchange minimum
🔔 Track HOWL — Get forecast alerts →

💹 Market Data

Market Cap$22.16M
Shares Outstanding48.60M
Float41.23M
Cash$46.45M
Debt$8.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 22.2% shares (2025Q4 vs prior)
51 institutional holders · 16.58M shares
#1 RA CAPITAL MANAGEMENT, L.P. 6.68M shares
#2 BANK OF AMERICA CORP /DE/ 2.57M shares
#3 VANGUARD GROUP INC 1.41M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest726.9K
Days to Cover2.4
% of Float1.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track HOWL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HOWL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HOWL
📊 HOWL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HOWL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.